Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel
Title: | Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel |
---|---|
Authors: | Andreas Peinelt, Melanie Bremm, Hermann Kreyenberg, Claudia Cappel, Julia Banisharif-Dehkordi, Stephanie Erben, Eva Rettinger, Andrea Jarisch, Roland Meisel, Paul-Gerhardt Schlegel, Olaf Beck, Gesine Bug, Jan-Henning Klusmann, Thomas Klingebiel, Sabine Huenecke, Peter Bader |
Source: | Frontiers in Immunology, Vol 13 (2022) |
Publisher Information: | Frontiers Media S.A., 2022. |
Publication Year: | 2022 |
Collection: | LCC:Immunologic diseases. Allergy |
Subject Terms: | acute lymphoblastic leukemia, chimeric antigen receptor (CAR), immunotherapy, flow cytometry, immune monitoring, Immunologic diseases. Allergy, RC581-607 |
More Details: | Chimeric antigen receptor (CAR) T cell therapy is a potent new treatment option for relapsed or refractory hematologic malignancies. As the monitoring of CAR T cell kinetics can provide insights into the activity of the therapy, appropriate CAR T cell detection methods are essential. Here, we report on the comprehensive validation of a flow cytometric assay for peripheral blood CD19 CAR T cell detection. Further, a retrospective analysis (n = 30) of CAR T cell and B cell levels over time has been performed, and CAR T cell phenotypes have been characterized. Serial dilution experiments demonstrated precise and linear quantification down to 0.05% of T cells or 22 CAR T cell events. The calculated detection limit at 13 events was confirmed with CAR T cell negative control samples. Inter-method comparison with real-time PCR showed appreciable correlation. Stability testing revealed diminished CAR T cell values already one day after sample collection. While we found long-term CAR T cell detectability and B cell aplasia in most patients (12/17), some patients (5/17) experienced B cell recovery. In three of these patients the coexistence of CAR T cells and regenerating B cells was observed. Repeat CAR T cell infusions led to detectable but limited re-expansions. Comparison of CAR T cell subsets with their counterparts among all T cells showed a significantly higher percentage of effector memory T cells and a significantly lower percentage of naïve T cells and T EMRA cells among CAR T cells. In conclusion, flow cytometric CAR T cell detection is a reliable method to monitor CAR T cells if measurements start without delay and sufficient T cell counts are given. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1664-3224 |
Relation: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.830773/full; https://doaj.org/toc/1664-3224 |
DOI: | 10.3389/fimmu.2022.830773 |
Access URL: | https://doaj.org/article/79daa92e8f4244719dcde74aa8452d48 |
Accession Number: | edsdoj.79daa92e8f4244719dcde74aa8452d48 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16643224&ISBN=&volume=13&issue=&date=20220301&spage=&pages=&title=Frontiers in Immunology&atitle=Monitoring%20of%20Circulating%20CAR%20T%20Cells%3A%20Validation%20of%20a%20Flow%20Cytometric%20Assay%2C%20Cellular%20Kinetics%2C%20and%20Phenotype%20Analysis%20Following%20Tisagenlecleucel&aulast=Andreas%20Peinelt&id=DOI:10.3389/fimmu.2022.830773 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/79daa92e8f4244719dcde74aa8452d48 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.79daa92e8f4244719dcde74aa8452d48 RelevancyScore: 938 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 937.625732421875 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Andreas+Peinelt%22">Andreas Peinelt</searchLink><br /><searchLink fieldCode="AR" term="%22Melanie+Bremm%22">Melanie Bremm</searchLink><br /><searchLink fieldCode="AR" term="%22Hermann+Kreyenberg%22">Hermann Kreyenberg</searchLink><br /><searchLink fieldCode="AR" term="%22Claudia+Cappel%22">Claudia Cappel</searchLink><br /><searchLink fieldCode="AR" term="%22Julia+Banisharif-Dehkordi%22">Julia Banisharif-Dehkordi</searchLink><br /><searchLink fieldCode="AR" term="%22Stephanie+Erben%22">Stephanie Erben</searchLink><br /><searchLink fieldCode="AR" term="%22Eva+Rettinger%22">Eva Rettinger</searchLink><br /><searchLink fieldCode="AR" term="%22Andrea+Jarisch%22">Andrea Jarisch</searchLink><br /><searchLink fieldCode="AR" term="%22Roland+Meisel%22">Roland Meisel</searchLink><br /><searchLink fieldCode="AR" term="%22Paul-Gerhardt+Schlegel%22">Paul-Gerhardt Schlegel</searchLink><br /><searchLink fieldCode="AR" term="%22Olaf+Beck%22">Olaf Beck</searchLink><br /><searchLink fieldCode="AR" term="%22Gesine+Bug%22">Gesine Bug</searchLink><br /><searchLink fieldCode="AR" term="%22Jan-Henning+Klusmann%22">Jan-Henning Klusmann</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas+Klingebiel%22">Thomas Klingebiel</searchLink><br /><searchLink fieldCode="AR" term="%22Sabine+Huenecke%22">Sabine Huenecke</searchLink><br /><searchLink fieldCode="AR" term="%22Peter+Bader%22">Peter Bader</searchLink> – Name: TitleSource Label: Source Group: Src Data: Frontiers in Immunology, Vol 13 (2022) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Frontiers Media S.A., 2022. – Name: DatePubCY Label: Publication Year Group: Date Data: 2022 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Immunologic diseases. Allergy – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22acute+lymphoblastic+leukemia%22">acute lymphoblastic leukemia</searchLink><br /><searchLink fieldCode="DE" term="%22chimeric+antigen+receptor+%28CAR%29%22">chimeric antigen receptor (CAR)</searchLink><br /><searchLink fieldCode="DE" term="%22immunotherapy%22">immunotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22flow+cytometry%22">flow cytometry</searchLink><br /><searchLink fieldCode="DE" term="%22immune+monitoring%22">immune monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Immunologic+diseases%2E+Allergy%22">Immunologic diseases. Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22RC581-607%22">RC581-607</searchLink> – Name: Abstract Label: Description Group: Ab Data: Chimeric antigen receptor (CAR) T cell therapy is a potent new treatment option for relapsed or refractory hematologic malignancies. As the monitoring of CAR T cell kinetics can provide insights into the activity of the therapy, appropriate CAR T cell detection methods are essential. Here, we report on the comprehensive validation of a flow cytometric assay for peripheral blood CD19 CAR T cell detection. Further, a retrospective analysis (n = 30) of CAR T cell and B cell levels over time has been performed, and CAR T cell phenotypes have been characterized. Serial dilution experiments demonstrated precise and linear quantification down to 0.05% of T cells or 22 CAR T cell events. The calculated detection limit at 13 events was confirmed with CAR T cell negative control samples. Inter-method comparison with real-time PCR showed appreciable correlation. Stability testing revealed diminished CAR T cell values already one day after sample collection. While we found long-term CAR T cell detectability and B cell aplasia in most patients (12/17), some patients (5/17) experienced B cell recovery. In three of these patients the coexistence of CAR T cells and regenerating B cells was observed. Repeat CAR T cell infusions led to detectable but limited re-expansions. Comparison of CAR T cell subsets with their counterparts among all T cells showed a significantly higher percentage of effector memory T cells and a significantly lower percentage of naïve T cells and T EMRA cells among CAR T cells. In conclusion, flow cytometric CAR T cell detection is a reliable method to monitor CAR T cells if measurements start without delay and sufficient T cell counts are given. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1664-3224 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://www.frontiersin.org/articles/10.3389/fimmu.2022.830773/full; https://doaj.org/toc/1664-3224 – Name: DOI Label: DOI Group: ID Data: 10.3389/fimmu.2022.830773 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/79daa92e8f4244719dcde74aa8452d48" linkWindow="_blank">https://doaj.org/article/79daa92e8f4244719dcde74aa8452d48</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.79daa92e8f4244719dcde74aa8452d48 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.79daa92e8f4244719dcde74aa8452d48 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.830773 Languages: – Text: English Subjects: – SubjectFull: acute lymphoblastic leukemia Type: general – SubjectFull: chimeric antigen receptor (CAR) Type: general – SubjectFull: immunotherapy Type: general – SubjectFull: flow cytometry Type: general – SubjectFull: immune monitoring Type: general – SubjectFull: Immunologic diseases. Allergy Type: general – SubjectFull: RC581-607 Type: general Titles: – TitleFull: Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andreas Peinelt – PersonEntity: Name: NameFull: Melanie Bremm – PersonEntity: Name: NameFull: Hermann Kreyenberg – PersonEntity: Name: NameFull: Claudia Cappel – PersonEntity: Name: NameFull: Julia Banisharif-Dehkordi – PersonEntity: Name: NameFull: Stephanie Erben – PersonEntity: Name: NameFull: Eva Rettinger – PersonEntity: Name: NameFull: Andrea Jarisch – PersonEntity: Name: NameFull: Roland Meisel – PersonEntity: Name: NameFull: Paul-Gerhardt Schlegel – PersonEntity: Name: NameFull: Olaf Beck – PersonEntity: Name: NameFull: Gesine Bug – PersonEntity: Name: NameFull: Jan-Henning Klusmann – PersonEntity: Name: NameFull: Thomas Klingebiel – PersonEntity: Name: NameFull: Sabine Huenecke – PersonEntity: Name: NameFull: Peter Bader IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 16643224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in Immunology Type: main |
ResultId | 1 |